Knome Raises $5.8M | GenomeWeb

NEW YORK (GenomeWeb News) – Knome has raised almost $5.8 million toward a targeted goal of $6.3 million, the bioinformatics firm said recently in a regulatory document.

The company did not respond to a request for comment. It did not say in its Form D filed with the US Securities and Exchange Commission who the investors are or how the funds would be used.

The securities offered were in the form of debt.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.